A 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP of the European Pharmacopoeia monograph is often referred to as a 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide Certificate of Suitability (COS). The purpose of a 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide to their clients by showing that a 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP has been issued for it. The manufacturer submits a 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP (COS) as part of the market authorization procedure, and it takes on the role of a 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP holder for the record. Additionally, the data presented in the 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide DMF.
A 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide suppliers with CEP (COS) on PharmaCompass.